Literature DB >> 16308103

Differential expression of Janus kinase 3 (JAK3), matrix metalloproteinase 13 (MMP13), heat shock protein 60 (HSP60), and mouse double minute 2 (MDM2) in human colorectal cancer progression using human cancer cDNA microarrays.

Daisuke Mori1, Yuji Nakafusa, Kohji Miyazaki, Osamu Tokunaga.   

Abstract

In this study, we applied commercially available cDNA microarray systems (1068 genes) to investigate the genetic changes in six colorectal cancers (CRC). Thirty-two genes fell into the group of commonly upregulated genes. In addition, we immunohistochemically investigated the expression of the four top ranked upregulated genes, Janus kinase 3 (JAK3), matrix metalloproteinase 13 (MMP13), heat shock protein 60 (HSP60), and mouse double minute 2 (MDM2), in 44 CRC. JAK3 staining was located in the cancer cells. A comparison of JAK3 immunostaining and clinicopathological parameters showed a significant association of tumor differentiation, pT, and TMN stage. Staining of MMP13 and HSP60 was noted mainly in the cytoplasm of cancer cells. A significant association of these expressions was observed with tumor differentiation and pT. MDM2 staining was noted in the nucleus of cancer and non-cancer cells. No significant association of clinicopathological parameters with MDM2 expression was observed. In multivariate analysis, JAK3 immunoreactivity showed independent prognostically unfavorable predictors. These data suggest that JAK3, in particular, is a highly significant, prognostic immunohistochemical marker in CRC. This study proves that cDNA microarrays, plotted by a small number of genes from a few samples, are both practical and useful.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16308103     DOI: 10.1016/j.prp.2005.06.005

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  12 in total

1.  Matrix metalloproteinase-13 expression in the progression of colorectal adenoma to carcinoma : Matrix metalloproteinase-13 expression in the colorectal adenoma and carcinoma.

Authors:  Abd Al-Rahman Mohammad Foda; Amira K El-Hawary; Azza Abdel-Aziz
Journal:  Tumour Biol       Date:  2014-02-23

2.  HSP60, a protein downregulated by IGFBP7 in colorectal carcinoma.

Authors:  Wenjing Ruan; Yinghong Wang; Yu Ma; Xiaoming Xing; Jie Lin; Jing Cui; Maode Lai
Journal:  J Exp Clin Cancer Res       Date:  2010-04-30

Review 3.  Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis.

Authors:  Maurizio Bellavia; Giovanni Tomasello; Marcello Romeo; Provvidenza Damiani; Attilio I Lo Monte; Luciano Lozio; Claudia Campanella; Antonella Marino Gammazza; Francesca Rappa; Giovanni Zummo; Massimo Cocchi; Everly Conway de Macario; Alberto J L Macario; Francesco Cappello
Journal:  Med Microbiol Immunol       Date:  2013-07-18       Impact factor: 3.402

4.  ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression.

Authors:  Kensuke Kumamoto; Kaori Fujita; Reiko Kurotani; Motonobu Saito; Motoko Unoki; Nobutoshi Hagiwara; Hideaki Shiga; Elise D Bowman; Nozomu Yanaihara; Shu Okamura; Makoto Nagashima; Kotaro Miyamoto; Seiichi Takenoshita; Jun Yokota; Curtis C Harris
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

5.  Matrix metalloproteinase-13 is regulated by toll-like receptor-9 in colorectal cancer cells and mediates cellular migration.

Authors:  Timo Rath; Julia Stöckle; Martin Roderfeld; Annette Tschuschner; Jürgen Graf; Elke Roeb
Journal:  Oncol Lett       Date:  2011-03-21       Impact factor: 2.967

6.  An association study of polymorphisms in JAK3 gene with lung cancer in the Korean population.

Authors:  Wonbeak Yoo; Hae-Yun Jung; Seungjoon Lim; Jae Sook Sung; Kyong Hwa Park; Jeong Seon Ryu; Sang Won Shin; Jun Suk Kim; Jae Hong Seo; Yeul Hong Kim
Journal:  Cancer Res Treat       Date:  2011-06-30       Impact factor: 4.679

7.  Identification and verification of heat shock protein 60 as a potential serum marker for colorectal cancer.

Authors:  Céline Hamelin; Emilie Cornut; Florence Poirier; Sylvie Pons; Corinne Beaulieu; Jean-Philippe Charrier; Hader Haïdous; Eddy Cotte; Claude Lambert; Françoise Piard; Yasemin Ataman-Önal; Geneviève Choquet-Kastylevsky
Journal:  FEBS J       Date:  2011-11-03       Impact factor: 5.542

8.  Heat shock proteins as danger signals for cancer detection.

Authors:  Renaud Seigneuric; Hajare Mjahed; Jessica Gobbo; Anne-Laure Joly; Kevin Berthenet; Sarah Shirley; Carmen Garrido
Journal:  Front Oncol       Date:  2011-11-10       Impact factor: 6.244

9.  Novel autoantigens immunogenic in COPD patients.

Authors:  Petra Leidinger; Andreas Keller; Sabrina Heisel; Nicole Ludwig; Stefanie Rheinheimer; Veronika Klein; Claudia Andres; Jürg Hamacher; Hanno Huwer; Bernhard Stephan; Ingo Stehle; Hans-Peter Lenhof; Eckart Meese
Journal:  Respir Res       Date:  2009-03-12

10.  Hsp60 exerts a tumor suppressor function by inducing cell differentiation and inhibiting invasion in hepatocellular carcinoma.

Authors:  Jing Zhang; Xingchun Zhou; Hulin Chang; Xiaojun Huang; Xu Guo; Xiaohong Du; Siyuan Tian; Lexiao Wang; Yinghua Lyv; Peng Yuan; Jinliang Xing
Journal:  Oncotarget       Date:  2016-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.